Christine K. Ward

3.0k citations

34 papers · 2.0k indexed · 1 hit paper · h-index 21

Physiology top 2%
Pulmonary and Respiratory Medicine top 5%
Immunology top 5%
Surgery top 10%
Molecular Biology

Co-authors: René van der Merwe Eric J. Hansen David Gossage Deepak Khatry Eugene R. Bleecker Jo L. Latimer Roland Kolbeck Sheryl R. Lumbley
Topics: Asthma and respiratory diseases (9 papers)Chronic Obstructive Pulmonary Disease (COPD) Research (8 papers)Syphilis Diagnosis and Treatment (6 papers)
Cited by: Microbiology Physiology Immunology
Journals: Blood Immunity The Journal of Immunology
Partner nations: United States United Kingdom Sweden

In The Last Decade

Christine K. Ward

31 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Benralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study

2014 362 citations Mario Castro, Sally E. Wenzel et al. The Lancet Respiratory Medicine profile →

Peers

Countries citing papers authored by Christine K. Ward

Since Specialization

Citations

This map shows the geographic impact of Christine K. Ward's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine K. Ward with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine K. Ward more than expected).

Fields of papers citing papers by Christine K. Ward

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christine K. Ward. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine K. Ward. The network helps show where Christine K. Ward may publish in the future.

Co-authorship network of co-authors of Christine K. Ward

This figure shows the co-authorship network connecting the top 25 collaborators of Christine K. Ward. A scholar is included among the top collaborators of Christine K. Ward based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christine K. Ward. Christine K. Ward is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical and Quantitative Pharmacology Considerations of mRNA Therapeutics and Vaccine Development: Bridging Translational and Platform Gaps for Enhanced Decision Making 2025 ·Clinical Pharmacology & Therapeutics ·(unknown),Nancy Chen,Kenji Miyazawa,Miao Zhang,Cornelia B. Landersdorfer,Carl M. J. Kirkpatrick,(unknown),Patrick F. Finn,Christine K. Ward,(unknown)	0
2	TAK-981, a First-in-Class SUMO-Activating Enzyme Inhibitor, Combined with Rituximab in Adult Patients (Pts) with CD20-Positive Relapsed/Refractory (R/R) Non-Hodgkin Lymphoma (NHL): Phase 1 Data 2021 ·Blood ·Sarit Assouline,Amitkumar Mehta,Tycel Phillips,Lapo Alinari,Alexey V. Danilov,Stéphane Doucet,Steven I. Park,Deborah Berg,(unknown),(unknown),Bo H. Chao,Allison Berger,John F. Gibbs,Sharon Friedlander,Christine K. Ward,Igor Proscurshim,Brenda Cooper,Paolo F. Caimi	4
3	476 First-in-human phase 1/2 study of the first-in-class SUMO-activating enzyme inhibitor TAK-981 in patients with advanced or metastatic solid tumors or relapsed/refractory lymphoma: phase 1 results 2021 ·Regular and Young Investigator Award Abstracts ·Arkadiusz Z. Dudek,Dejan Juric,Afshin Dowlati,Ulka N. Vaishampayan,(unknown),Jordi Rodón,Bo H. Chao,Bingxia Wang,John F. Gibbs,Vaishali Shinde,Sharon Friedlander,Allison Berger,Christine K. Ward,(unknown),Robert Gharavi,(unknown),Igor Proscurshim,Anthony J. Olszanski	10
4	Bronchial mucosal IFN-α/β and pattern recognition receptor expression in patients with experimental rhinovirus-induced asthma exacerbations 2018 ·Journal of Allergy and Clinical Immunology ·Jie Zhu,Simon Message,Patrick Mallia,Tatiana Kebadze,Marco Contoli,Christine K. Ward,Elliot S. Barnathan,Mary Ann Mascelli,Onn Min Kon,Alberto Papi,L Stanciu,Michael R. Edwards,Peter K. Jeffery,Sebastian L. Johnston	65
5	IL-18 associated with lung lymphoid aggregates drives IFNγ production in severe COPD 2017 ·Respiratory Research ·Emmanuel Briend,Gail Ferguson,Michiko Mori,Gautam Damera,Katherine Stephenson,Natasha A. Karp,Sanjay Sethi,Christine K. Ward,Matthew A. Sleeman,Jonas S. Erjefält,Donna K. Finch	20
6	A randomised, placebo-controlled trial of anti–interleukin-1 receptor 1 monoclonal antibody MEDI8968 in chronic obstructive pulmonary disease 2017 ·Respiratory Research ·Peter M.A. Calverley,Sanjay Sethi,Michelle Dawson,Christine K. Ward,Donna K. Finch,Mark Penney,Paul Newbold,René van der Merwe	74
7	A Sputum Proteomic Signature That Associates with Increased IL-1β Levels and Bacterial Exacerbations of COPD 2016 ·Lung ·Gautam Damera,Tuyet‐Hang Pham,Jianchun Zhang,Christine K. Ward,Paul Newbold,Koustubh Ranade,Sanjay Sethi	23
8	Cigarette Smoke Silences Innate Lymphoid Cell Function and Facilitates an Exacerbated Type I Interleukin-33-Dependent Response to Infection 2015 ·Immunity ·Jennifer Kearley,Jonathan S. Silver,Caroline Sandén,Zheng Liu,Aaron A. Berlin,(unknown),Michiko Mori,Tuyet‐Hang Pham,Christine K. Ward,Gerard J. Criner,Nathaniel Marchetti,Tomas Mustelin,Jonas S. Erjefält,Roland Kolbeck,Alison A. Humbles	255
9	Distribution of blood eosinophil in COPD patients 2014 ·European Respiratory Journal ·Trung N. Tran,Hervé Caspard,Christine K. Ward,(unknown)	1
10	Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study 2014 ·The Lancet Respiratory Medicine ·Christopher E. Brightling,Eugene R. Bleecker,Reynold A. Panettieri,Mona Bafadhel,Dewei She,Christine K. Ward,Xiao Xu,Claire Birrell,René van der Merwe	225
11	High blood eosinophil count is associated with more frequent asthma attacks in asthma patients 2014 ·Annals of Allergy Asthma & Immunology ·Trung N. Tran,Deepak Khatry,(unknown),Christine K. Ward,David Gossage	137
12	Airway Inflammation and Illness Severity in Response to Experimental Rhinovirus Infection in Asthma 2014 ·CHEST Journal ·Jie Zhu,Simon Message,Yusheng Qiu,Patrick Mallia,Tatiana Kebadze,Marco Contoli,Christine K. Ward,Elliot S. Barnathan,Mary Ann Mascelli,Onn Min Kon,Alberto Papi,L Stanciu,Peter K. Jeffery,Sebastian L. Johnston	74
13	Benralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging studybreakdown → 2014 ·The Lancet Respiratory Medicine ·Mario Castro,Sally E. Wenzel,Eugene R. Bleecker,Emílio Pizzichini,Piotr Kuna,William W. Busse,David Gossage,Christine K. Ward,Yanping Wu,Bing Wang,Deepak Khatry,René van der Merwe,Roland Kolbeck,Néstor A. Molfino,Donald G. Raible	362
14	Novel antagonist antibody to TLR3 blocks poly(I:C)-induced inflammation in vivo and in vitro 2010 ·Cellular Immunology ·(unknown),Karen E. Duffy,Roberta J. Lamb,Lani R. San Mateo,(unknown),(unknown),Xuesong Liu,Ted Petley,(unknown),Heena Beck,Richard A. Flavell,Lena Alexopoulou,Christine K. Ward	16
15	Critical community psychology in practice – examples from a chronic pain service 2004 ·Christine K. Ward	1
16	Identification of theznuA-Encoded Periplasmic Zinc Transport Protein ofHaemophilus ducreyi 1999 ·Infection and Immunity ·David A. Lewis,Julia Klesney‐Tait,Sheryl R. Lumbley,Christine K. Ward,Jo L. Latimer,C A Ison,Eric J. Hansen	76
17	Cloning and Mutagenesis of a Serotype-Specific DNA Region Involved in Encapsulation and Virulence ofActinobacillus pleuropneumoniaeSerotype 5a: Concomitant Expression of Serotype 5a and 1 Capsular Polysaccharides in RecombinantA. pleuropneumoniaeSerotype 1 1998 ·Infection and Immunity ·Christine K. Ward,Mark L. Lawrence,Hugo P. Veit,Thomas J. Inzana	39
18	Identification and characterization of a DNA region involved in the export of capsular polysaccharide by Actinobacillus pleuropneumoniae serotype 5a 1997 ·Infection and Immunity ·Christine K. Ward,(unknown)	42
19	Lumbar Muscle Usage in Chronic Low Back Pain 1993 ·Spine ·(unknown),(unknown),(unknown),Jerri Payne,Christine K. Ward,Tom G. Mayer,Robert W. Parkey,Ronald M. Peshock	70
20	Competitive migration of -alkyl groups in the Baeyer-Villiger oxidation 1971 ·Tetrahedron Letters ·S. A. MONTI,Christine K. Ward	5

About Christine K. Ward

Christine K. Ward is a scholar working on Microbiology, Physiology and Emergency Medical Services, having authored 34 papers that have together received 2.0k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (9 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (8 papers) and Syphilis Diagnosis and Treatment (6 papers). The work is most often cited by research in Microbiology (244 citations), Physiology (982 citations) and Immunology (620 citations). Christine K. Ward has collaborated with scholars based in United States, United Kingdom and Sweden. Frequent co-authors include René van der Merwe, Eric J. Hansen, David Gossage, Deepak Khatry, Eugene R. Bleecker, Jo L. Latimer, Roland Kolbeck, Sheryl R. Lumbley, Trung N. Tran and Leslie D. Cope. Their work appears in journals such as Blood, Immunity and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact